Suppr超能文献

多巴胺D2受体(DRD2)作为肥胖和身高的一个主要基因。

The dopamine D2 receptor (DRD2) as a major gene in obesity and height.

作者信息

Comings D E, Flanagan S D, Dietz G, Muhleman D, Knell E, Gysin R

机构信息

Department of Medical Genetics, Beckman Research Institute, City of Hope Medical Center, Duarte, California 91010.

出版信息

Biochem Med Metab Biol. 1993 Oct;50(2):176-85. doi: 10.1006/bmmb.1993.1059.

Abstract

Dopamine plays a major role in the regulation of appetite and growth hormone. Dopaminergic agonists suppress appetite and dopamine D2 receptor antagonists enhance it. We examined the hypothesis that allelic variants of the DRD2 locus may be associated with weight and height. Sarkar and Sommer described two DRD2 polymorphisms that could be haplotyped by PCR. For weight, the mean Z score (National Center for Health Statistics) for 208 subjects without haplotype 4 was 0.086 versus 0.557 for 280 subjects with haplotype 4, P = 0.0003. Two separate sets of subjects were studied and these results were significant for both, providing an internal replication. For height, the mean Z score for 164 subjects without haplotype 4 was 0.1677 versus 0.6885 for 219 subjects with haplotype 4, P < 0.00001. These and other data suggest that the 4 haplotype is in linkage disequilibrium with allelic variants of the DRD2 gene that play a major role in the regulation of weight (obesity) and height, and may serve as a risk factor in late-onset non-insulin-dependent diabetes mellitus (NIDDM).

摘要

多巴胺在食欲和生长激素的调节中起主要作用。多巴胺能激动剂会抑制食欲,而多巴胺D2受体拮抗剂则会增强食欲。我们检验了DRD2基因座的等位基因变体可能与体重和身高相关的假设。萨卡尔和索默描述了两种可通过聚合酶链反应(PCR)进行单倍型分型的DRD2多态性。就体重而言,208名没有单倍型4的受试者的平均Z分数(美国国家卫生统计中心标准)为0.086,而280名有单倍型4的受试者的平均Z分数为0.557,P = 0.0003。我们对两组不同的受试者进行了研究,两组结果均具有显著性,实现了内部重复验证。就身高而言,164名没有单倍型4的受试者的平均Z分数为0.1677,而219名有单倍型4的受试者的平均Z分数为0.6885,P < 0.00001。这些数据以及其他数据表明,单倍型4与DRD2基因的等位基因变体处于连锁不平衡状态,这些变体在体重(肥胖)和身高的调节中起主要作用,并且可能是晚发型非胰岛素依赖型糖尿病(NIDDM)的一个风险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验